- Clinical Cell Culture
Infobox Company
company_name = Clinical Cell Culture
company_
company_type =Public company (asx|CCE)
genre =
foundation = 1999
founder =Fiona Wood
location_city =Cambridge ;Perth, Western Australia ;Coral Springs, Florida
location_country =
location =
origins =
key_people = Andrew Cannon, Chief Executive
area_served = Global
industry = Surgical medicine
products = Artificial skin
services = Burns treatments
revenue =
operating_income =
net_income =
num_employees =
parent =
divisions =
subsid =
owner =
company_slogan =
homepage = http://www.clinicalcellculture.com/
dissolved =
footnotes =Clinical Cell Culture (C3) asx|CCE, is a company founded by
Fiona Wood which aims to develop and marketspray-on skin processes, especially for the treatment of skin trauma and burns victims.It products are known as CellSpray and ReCell.
Clinical Cell Culture | C3 | is a publicly listed company on the Australian Stock Exchange(ASX), trading under the symbol CCE. [ [http://www.asx.com.au/asx/research/CompanyInfoSearchResults.jsp?searchBy=asxCode&allinfo=on&asxCode=CCE&companyName=&principalActivity=&industryGroup=NO/ ASX details] ]
In March 2007, the company announced a restructure and a new Chief Executive Officer following a previous half-year loss of $5 million. [ [http://www.abc.net.au/news/newsitems/200703/s1884857.htm "Clinical Cell Culture to tighten operations"] ABC News Online. March 29, 2007]
The company restructured and was renamed "Visiomed" in June 2008. [http://www.visiomed.com.au/]
References
External links
* [http://www.clinicalcellculture.com/ C3 website]
Wikimedia Foundation. 2010.